Clinical Trials Directory

Trials / Terminated

TerminatedNCT03015051

High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis

Randomized Controlled Trial to Compare the Efficacy of High Flow Nasal Cannula Oxygen Therapy vs Low Flow Oxygen Therapy in Bronchiolitis

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
IRCCS Burlo Garofolo · Academic / Other
Sex
All
Age
6 Months
Healthy volunteers
Not accepted

Summary

Bronchiolitis is the most common respiratory infection of the lower respiratory tract that affects 11-12% of infants in their first year of life. Approximately 1-2% of patients with bronchiolitis require hospital admission because of poor feeding and/or breathing difficulties. The standard treatment for bronchiolitis is represented by oxygen-therapy and hydration while neither steroids nor epinephrine nor bronchodilators are recommended. One of the techniques of administration of oxygen in bronchiolitis is represented by the high flow (HFNC) or by a system in which oxygen is delivered to 2L/kg through nasal cannulas. The HFNC provides humidification, heating and oxygen, ensuring a minimum positive pressure, reduces breathing load and allows for better nutrition. The main aim of therapy with high flows is to reduce the days of oxygen therapy and the cases of intubation. However, up to now, there have been few studies on the use of HFNC in Pediatric Emergency Units. The Cochrane review on this topic, updated in May 2013, included only one randomized controlled trial (RCT) on a pilot study of 19 subjects comparing HFNC with oxygen administered via "head box". The oxygen saturation was higher in children HFNC after 8 (00% versus 96%, p=0.04) and 12 hours (99% vs 96%, p=0.04) but similar in both groups at 24 hours. The authors concluded that the available evidence is insufficient to determine the effectiveness of HFNC. The aim of this study is to evaluate in a large number of cases the effectiveness of treatment with high flow versus standard treatment, in children with bronchiolitis referred to a Pediatric Emergency Department.

Conditions

Interventions

TypeNameDescription
DRUGOxygen

Timeline

Start date
2017-01-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2017-01-09
Last updated
2020-09-04

Locations

15 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT03015051. Inclusion in this directory is not an endorsement.